nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ORM1—Propranolol—migraine	0.105	0.161	CbGbCtD
Tacrolimus—ORM1—Amitriptyline—migraine	0.0906	0.139	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Propranolol—migraine	0.0472	0.0724	CbGbCtD
Tacrolimus—CYP3A7—Propranolol—migraine	0.0472	0.0724	CbGbCtD
Tacrolimus—ALB—Amitriptyline—migraine	0.0381	0.0585	CbGbCtD
Tacrolimus—CYP3A5—Propranolol—migraine	0.0354	0.0543	CbGbCtD
Tacrolimus—CYP3A7—Verapamil—migraine	0.0324	0.0497	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Verapamil—migraine	0.0324	0.0497	CbGbCtD
Tacrolimus—CYP3A5—Amitriptyline—migraine	0.0306	0.047	CbGbCtD
Tacrolimus—CYP3A5—Valproic Acid—migraine	0.0279	0.0428	CbGbCtD
Tacrolimus—ABCB1—Timolol—migraine	0.0259	0.0397	CbGbCtD
Tacrolimus—CYP3A5—Verapamil—migraine	0.0243	0.0373	CbGbCtD
Tacrolimus—ABCB1—Propranolol—migraine	0.0231	0.0354	CbGbCtD
Tacrolimus—ABCB1—Amitriptyline—migraine	0.0199	0.0306	CbGbCtD
Tacrolimus—ABCB1—Verapamil—migraine	0.0158	0.0243	CbGbCtD
Tacrolimus—CYP3A4—Propranolol—migraine	0.0138	0.0212	CbGbCtD
Tacrolimus—CYP3A4—Amitriptyline—migraine	0.012	0.0183	CbGbCtD
Tacrolimus—CYP3A4—Valproic Acid—migraine	0.0109	0.0167	CbGbCtD
Tacrolimus—CYP3A4—Topiramate—migraine	0.00983	0.0151	CbGbCtD
Tacrolimus—CYP3A4—Verapamil—migraine	0.00948	0.0145	CbGbCtD
Tacrolimus—PPP3CA—pons—migraine	0.00844	0.17	CbGeAlD
Tacrolimus—ABCA5—trigeminal ganglion—migraine	0.00314	0.0633	CbGeAlD
Tacrolimus—MTOR—blood vessel—migraine	0.00254	0.0511	CbGeAlD
Tacrolimus—PPP3CA—trigeminal ganglion—migraine	0.00212	0.0427	CbGeAlD
Tacrolimus—PPP3CA—brainstem—migraine	0.00188	0.0378	CbGeAlD
Tacrolimus—MTOR—neck—migraine	0.00182	0.0366	CbGeAlD
Tacrolimus—MTOR—EGFR-dependent Endothelin signaling events—EDNRA—migraine	0.00166	0.0552	CbGpPWpGaD
Tacrolimus—FKBP1A—neck—migraine	0.00163	0.0329	CbGeAlD
Tacrolimus—MTOR—Type II diabetes mellitus—CACNA1A—migraine	0.00155	0.0514	CbGpPWpGaD
Tacrolimus—ABCA5—head—migraine	0.00154	0.0309	CbGeAlD
Tacrolimus—PPP3CA—cardiovascular system—migraine	0.00153	0.0309	CbGeAlD
Tacrolimus—ABCA5—nervous system—migraine	0.00146	0.0293	CbGeAlD
Tacrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR2—migraine	0.00145	0.048	CbGpPWpGaD
Tacrolimus—FKBP1A—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MEF2D—migraine	0.00144	0.0479	CbGpPWpGaD
Tacrolimus—FKBP1A—trigeminal ganglion—migraine	0.00141	0.0284	CbGeAlD
Tacrolimus—ABCA5—central nervous system—migraine	0.0014	0.0282	CbGeAlD
Tacrolimus—MTOR—brainstem—migraine	0.00139	0.0279	CbGeAlD
Tacrolimus—ABCA5—cerebellum—migraine	0.00137	0.0276	CbGeAlD
Tacrolimus—MTOR—cardiovascular system—migraine	0.00113	0.0228	CbGeAlD
Tacrolimus—ABCA5—brain—migraine	0.00111	0.0224	CbGeAlD
Tacrolimus—PPP3CA—head—migraine	0.00104	0.0209	CbGeAlD
Tacrolimus—FKBP1A—cardiovascular system—migraine	0.00102	0.0205	CbGeAlD
Tacrolimus—PPP3CA—Alzheimers Disease—LRP1—migraine	0.001	0.0333	CbGpPWpGaD
Tacrolimus—PPP3CA—nervous system—migraine	0.000984	0.0198	CbGeAlD
Tacrolimus—FKBP1A—ALK1 signaling events—TGFBR2—migraine	0.000981	0.0326	CbGpPWpGaD
Tacrolimus—PPP3CA—central nervous system—migraine	0.000948	0.0191	CbGeAlD
Tacrolimus—PPP3CA—cerebellum—migraine	0.000926	0.0186	CbGeAlD
Tacrolimus—ALB—Scavenging of heme from plasma—LRP1—migraine	0.000909	0.0302	CbGpPWpGaD
Tacrolimus—PPP3CA—Physiological and Pathological Hypertrophy  of the Heart—FOS—migraine	0.000849	0.0282	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR2—migraine	0.00083	0.0276	CbGpPWpGaD
Tacrolimus—MTOR—head—migraine	0.000767	0.0154	CbGeAlD
Tacrolimus—PPP3CA—brain—migraine	0.000752	0.0151	CbGeAlD
Tacrolimus—MTOR—nervous system—migraine	0.000727	0.0146	CbGeAlD
Tacrolimus—MTOR—IL4-mediated signaling events—LTA—migraine	0.000727	0.0241	CbGpPWpGaD
Tacrolimus—MTOR—central nervous system—migraine	0.0007	0.0141	CbGeAlD
Tacrolimus—FKBP1A—head—migraine	0.00069	0.0139	CbGeAlD
Tacrolimus—MTOR—cerebellum—migraine	0.000684	0.0138	CbGeAlD
Tacrolimus—FKBP1A—nervous system—migraine	0.000654	0.0132	CbGeAlD
Tacrolimus—FKBP1A—central nervous system—migraine	0.00063	0.0127	CbGeAlD
Tacrolimus—FKBP1A—cerebellum—migraine	0.000615	0.0124	CbGeAlD
Tacrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000596	0.0198	CbGpPWpGaD
Tacrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.000585	0.0194	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling—TGFBR2—migraine	0.000563	0.0187	CbGpPWpGaD
Tacrolimus—MTOR—brain—migraine	0.000556	0.0112	CbGeAlD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR2—migraine	0.000546	0.0181	CbGpPWpGaD
Tacrolimus—ABCB1—blood vessel—migraine	0.000528	0.0106	CbGeAlD
Tacrolimus—MTOR—FSH signaling pathway—BDNF—migraine	0.000515	0.0171	CbGpPWpGaD
Tacrolimus—ORM1—nervous system—migraine	0.000512	0.0103	CbGeAlD
Tacrolimus—FKBP1A—brain—migraine	0.0005	0.0101	CbGeAlD
Tacrolimus—ORM1—central nervous system—migraine	0.000493	0.00992	CbGeAlD
Tacrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—migraine	0.000492	0.0163	CbGpPWpGaD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR2—migraine	0.000444	0.0147	CbGpPWpGaD
Tacrolimus—PPP3CA—BCR signaling pathway—FOS—migraine	0.000386	0.0128	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—BDNF—migraine	0.000363	0.0121	CbGpPWpGaD
Tacrolimus—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000363	0.012	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—FOS—migraine	0.000355	0.0118	CbGpPWpGaD
Tacrolimus—ALB—brain—migraine	0.000343	0.00691	CbGeAlD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000337	0.0112	CbGpPWpGaD
Tacrolimus—PPP3CA—Amyotrophic lateral sclerosis (ALS)—TNF—migraine	0.000326	0.0108	CbGpPWpGaD
Tacrolimus—ABCB1—trigeminal ganglion—migraine	0.000326	0.00657	CbGeAlD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TGFBR2—migraine	0.000284	0.00944	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—BDNF—migraine	0.000281	0.00935	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—BDNF—migraine	0.000274	0.00909	CbGpPWpGaD
Tacrolimus—MTOR—LKB1 signaling events—ESR1—migraine	0.000266	0.00884	CbGpPWpGaD
Tacrolimus—MTOR—ErbB2/ErbB3 signaling events—FOS—migraine	0.000249	0.00828	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—FOS—migraine	0.000245	0.00815	CbGpPWpGaD
Tacrolimus—PPP3CA—Cardiac Hypertrophic Response—TNF—migraine	0.000243	0.00807	CbGpPWpGaD
Tacrolimus—ABCB1—cardiovascular system—migraine	0.000236	0.00474	CbGeAlD
Tacrolimus—MTOR—Type II diabetes mellitus—TNF—migraine	0.00022	0.00732	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—RAMP1—migraine	0.000219	0.00727	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CALCRL—migraine	0.000219	0.00727	CbGpPWpGaD
Tacrolimus—CYP3A4—nervous system—migraine	0.000214	0.0043	CbGeAlD
Tacrolimus—CYP3A4—central nervous system—migraine	0.000206	0.00414	CbGeAlD
Tacrolimus—MTOR—RANKL/RANK Signaling Pathway—FOS—migraine	0.000197	0.00654	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000191	0.00636	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—migraine	0.000191	0.00635	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—FOS—migraine	0.00019	0.00632	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—FOS—migraine	0.000185	0.00614	CbGpPWpGaD
Tacrolimus—MTOR—Regulation of Telomerase—ESR1—migraine	0.000184	0.00613	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—FOS—migraine	0.000184	0.0061	CbGpPWpGaD
Tacrolimus—PPP3CA—Alzheimers Disease—TNF—migraine	0.000182	0.00604	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—PGR—migraine	0.000182	0.00603	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000177	0.00589	CbGpPWpGaD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000173	0.00575	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—FOS—migraine	0.000172	0.00573	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—ESR1—migraine	0.000171	0.00567	CbGpPWpGaD
Tacrolimus—MTOR—TSH signaling pathway—FOS—migraine	0.00017	0.00566	CbGpPWpGaD
Tacrolimus—MTOR—Regulation of Telomerase—FOS—migraine	0.000166	0.00552	CbGpPWpGaD
Tacrolimus—ABCB1—head—migraine	0.00016	0.00321	CbGeAlD
Tacrolimus—PPP3CA—Signaling by GPCR—HTR1D—migraine	0.000159	0.00528	CbGpPWpGaD
Tacrolimus—ABCB1—nervous system—migraine	0.000151	0.00304	CbGeAlD
Tacrolimus—PPP3CA—Signaling by GPCR—HTR2B—migraine	0.000148	0.00491	CbGpPWpGaD
Tacrolimus—ABCB1—central nervous system—migraine	0.000146	0.00293	CbGeAlD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000144	0.00477	CbGpPWpGaD
Tacrolimus—ABCB1—cerebellum—migraine	0.000142	0.00287	CbGeAlD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000135	0.00448	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—BDNF—migraine	0.000135	0.00448	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—TNF—migraine	0.000132	0.00438	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RAMP1—migraine	0.000129	0.00429	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CALCRL—migraine	0.000129	0.00429	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.000128	0.00426	CbGpPWpGaD
Tacrolimus—MTOR—ErbB1 downstream signaling—FOS—migraine	0.000117	0.0039	CbGpPWpGaD
Tacrolimus—ABCB1—brain—migraine	0.000116	0.00233	CbGeAlD
Tacrolimus—Oedema—Valproic Acid—migraine	0.00011	0.00041	CcSEcCtD
Tacrolimus—Anaphylactic shock—Valproic Acid—migraine	0.00011	0.00041	CcSEcCtD
Tacrolimus—Bradycardia—Topiramate—migraine	0.00011	0.00041	CcSEcCtD
Tacrolimus—Pruritus—Verapamil—migraine	0.00011	0.000409	CcSEcCtD
Tacrolimus—PPP3CA—Disease—LRP1—migraine	0.00011	0.00364	CbGpPWpGaD
Tacrolimus—Tension—Gabapentin—migraine	0.00011	0.000409	CcSEcCtD
Tacrolimus—Dysgeusia—Gabapentin—migraine	0.000109	0.000408	CcSEcCtD
Tacrolimus—Infection—Valproic Acid—migraine	0.000109	0.000408	CcSEcCtD
Tacrolimus—Haemoglobin—Topiramate—migraine	0.000109	0.000405	CcSEcCtD
Tacrolimus—Nervousness—Gabapentin—migraine	0.000109	0.000405	CcSEcCtD
Tacrolimus—Rhinitis—Topiramate—migraine	0.000108	0.000404	CcSEcCtD
Tacrolimus—Back pain—Gabapentin—migraine	0.000108	0.000403	CcSEcCtD
Tacrolimus—Haemorrhage—Topiramate—migraine	0.000108	0.000403	CcSEcCtD
Tacrolimus—Hepatitis—Topiramate—migraine	0.000108	0.000403	CcSEcCtD
Tacrolimus—Nervous system disorder—Valproic Acid—migraine	0.000108	0.000402	CcSEcCtD
Tacrolimus—Vertigo—Timolol—migraine	0.000108	0.000402	CcSEcCtD
Tacrolimus—Thrombocytopenia—Valproic Acid—migraine	0.000108	0.000402	CcSEcCtD
Tacrolimus—Syncope—Timolol—migraine	0.000108	0.000401	CcSEcCtD
Tacrolimus—Hypoaesthesia—Topiramate—migraine	0.000107	0.000401	CcSEcCtD
Tacrolimus—Hallucination—Topiramate—migraine	0.000107	0.000401	CcSEcCtD
Tacrolimus—Muscle spasms—Gabapentin—migraine	0.000107	0.000401	CcSEcCtD
Tacrolimus—Tachycardia—Valproic Acid—migraine	0.000107	0.0004	CcSEcCtD
Tacrolimus—Vomiting—Propranolol—migraine	0.000107	0.0004	CcSEcCtD
Tacrolimus—Pharyngitis—Topiramate—migraine	0.000107	0.0004	CcSEcCtD
Tacrolimus—Skin disorder—Valproic Acid—migraine	0.000107	0.000398	CcSEcCtD
Tacrolimus—Urinary tract disorder—Topiramate—migraine	0.000107	0.000398	CcSEcCtD
Tacrolimus—Oedema peripheral—Topiramate—migraine	0.000106	0.000397	CcSEcCtD
Tacrolimus—Hyperhidrosis—Valproic Acid—migraine	0.000106	0.000397	CcSEcCtD
Tacrolimus—Rash—Propranolol—migraine	0.000106	0.000397	CcSEcCtD
Tacrolimus—Dermatitis—Propranolol—migraine	0.000106	0.000396	CcSEcCtD
Tacrolimus—Diarrhoea—Verapamil—migraine	0.000106	0.000396	CcSEcCtD
Tacrolimus—Connective tissue disorder—Topiramate—migraine	0.000106	0.000396	CcSEcCtD
Tacrolimus—Palpitations—Timolol—migraine	0.000106	0.000395	CcSEcCtD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—TNF—migraine	0.000106	0.00352	CbGpPWpGaD
Tacrolimus—Urethral disorder—Topiramate—migraine	0.000106	0.000395	CcSEcCtD
Tacrolimus—Loss of consciousness—Timolol—migraine	0.000105	0.000393	CcSEcCtD
Tacrolimus—Vision blurred—Gabapentin—migraine	0.000105	0.000393	CcSEcCtD
Tacrolimus—Anorexia—Valproic Acid—migraine	0.000105	0.000391	CcSEcCtD
Tacrolimus—Cough—Timolol—migraine	0.000105	0.00039	CcSEcCtD
Tacrolimus—Tremor—Gabapentin—migraine	0.000105	0.00039	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—MTHFR—migraine	0.000104	0.00347	CbGpPWpGaD
Tacrolimus—Visual impairment—Topiramate—migraine	0.000104	0.000388	CcSEcCtD
Tacrolimus—Ill-defined disorder—Gabapentin—migraine	0.000104	0.000387	CcSEcCtD
Tacrolimus—Hypertension—Timolol—migraine	0.000104	0.000386	CcSEcCtD
Tacrolimus—Anaemia—Gabapentin—migraine	0.000103	0.000385	CcSEcCtD
Tacrolimus—Hypotension—Valproic Acid—migraine	0.000103	0.000383	CcSEcCtD
Tacrolimus—Agitation—Gabapentin—migraine	0.000103	0.000383	CcSEcCtD
Tacrolimus—Dizziness—Verapamil—migraine	0.000103	0.000383	CcSEcCtD
Tacrolimus—FKBP1A—Spinal Cord Injury—TNF—migraine	0.000102	0.0034	CbGpPWpGaD
Tacrolimus—Chest pain—Timolol—migraine	0.000102	0.000381	CcSEcCtD
Tacrolimus—Arthralgia—Timolol—migraine	0.000102	0.000381	CcSEcCtD
Tacrolimus—Myalgia—Timolol—migraine	0.000102	0.000381	CcSEcCtD
Tacrolimus—Erythema multiforme—Topiramate—migraine	0.000102	0.000381	CcSEcCtD
Tacrolimus—Anxiety—Timolol—migraine	0.000102	0.00038	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000101	0.000378	CcSEcCtD
Tacrolimus—Discomfort—Timolol—migraine	0.000101	0.000376	CcSEcCtD
Tacrolimus—Eye disorder—Topiramate—migraine	0.000101	0.000376	CcSEcCtD
Tacrolimus—Malaise—Gabapentin—migraine	0.000101	0.000376	CcSEcCtD
Tacrolimus—Tinnitus—Topiramate—migraine	0.000101	0.000375	CcSEcCtD
Tacrolimus—Vertigo—Gabapentin—migraine	0.0001	0.000374	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Valproic Acid—migraine	0.0001	0.000374	CcSEcCtD
Tacrolimus—Flushing—Topiramate—migraine	0.0001	0.000374	CcSEcCtD
Tacrolimus—Cardiac disorder—Topiramate—migraine	0.0001	0.000374	CcSEcCtD
Tacrolimus—Syncope—Gabapentin—migraine	0.0001	0.000374	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—CALCRL—migraine	0.0001	0.00333	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RAMP1—migraine	0.0001	0.00333	CbGpPWpGaD
Tacrolimus—Nausea—Propranolol—migraine	0.0001	0.000374	CcSEcCtD
Tacrolimus—Leukopenia—Gabapentin—migraine	0.0001	0.000373	CcSEcCtD
Tacrolimus—Dry mouth—Timolol—migraine	9.99e-05	0.000373	CcSEcCtD
Tacrolimus—Insomnia—Valproic Acid—migraine	9.95e-05	0.000371	CcSEcCtD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TNF—migraine	9.94e-05	0.0033	CbGpPWpGaD
Tacrolimus—Paraesthesia—Valproic Acid—migraine	9.88e-05	0.000368	CcSEcCtD
Tacrolimus—Palpitations—Gabapentin—migraine	9.87e-05	0.000368	CcSEcCtD
Tacrolimus—Confusional state—Timolol—migraine	9.87e-05	0.000368	CcSEcCtD
Tacrolimus—Vomiting—Verapamil—migraine	9.86e-05	0.000368	CcSEcCtD
Tacrolimus—Loss of consciousness—Gabapentin—migraine	9.82e-05	0.000366	CcSEcCtD
Tacrolimus—Dyspnoea—Valproic Acid—migraine	9.81e-05	0.000366	CcSEcCtD
Tacrolimus—Angiopathy—Topiramate—migraine	9.8e-05	0.000365	CcSEcCtD
Tacrolimus—Oedema—Timolol—migraine	9.79e-05	0.000365	CcSEcCtD
Tacrolimus—Anaphylactic shock—Timolol—migraine	9.79e-05	0.000365	CcSEcCtD
Tacrolimus—Rash—Verapamil—migraine	9.78e-05	0.000365	CcSEcCtD
Tacrolimus—Somnolence—Valproic Acid—migraine	9.78e-05	0.000365	CcSEcCtD
Tacrolimus—ALB—Transmembrane transport of small molecules—TRPM8—migraine	9.78e-05	0.00325	CbGpPWpGaD
Tacrolimus—Dermatitis—Verapamil—migraine	9.77e-05	0.000364	CcSEcCtD
Tacrolimus—Immune system disorder—Topiramate—migraine	9.75e-05	0.000364	CcSEcCtD
Tacrolimus—Cough—Gabapentin—migraine	9.75e-05	0.000364	CcSEcCtD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—ESR1—migraine	9.74e-05	0.00324	CbGpPWpGaD
Tacrolimus—Mediastinal disorder—Topiramate—migraine	9.73e-05	0.000363	CcSEcCtD
Tacrolimus—Infection—Timolol—migraine	9.73e-05	0.000363	CcSEcCtD
Tacrolimus—Headache—Verapamil—migraine	9.72e-05	0.000362	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB4—ESR1—migraine	9.69e-05	0.00322	CbGpPWpGaD
Tacrolimus—Chills—Topiramate—migraine	9.69e-05	0.000361	CcSEcCtD
Tacrolimus—Dyspepsia—Valproic Acid—migraine	9.68e-05	0.000361	CcSEcCtD
Tacrolimus—Convulsion—Gabapentin—migraine	9.68e-05	0.000361	CcSEcCtD
Tacrolimus—Hypertension—Gabapentin—migraine	9.65e-05	0.00036	CcSEcCtD
Tacrolimus—Shock—Timolol—migraine	9.63e-05	0.000359	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—HTR1B—migraine	9.63e-05	0.0032	CbGpPWpGaD
Tacrolimus—Nervous system disorder—Timolol—migraine	9.6e-05	0.000358	CcSEcCtD
Tacrolimus—Decreased appetite—Valproic Acid—migraine	9.56e-05	0.000357	CcSEcCtD
Tacrolimus—Alopecia—Topiramate—migraine	9.54e-05	0.000356	CcSEcCtD
Tacrolimus—Myalgia—Gabapentin—migraine	9.51e-05	0.000355	CcSEcCtD
Tacrolimus—Chest pain—Gabapentin—migraine	9.51e-05	0.000355	CcSEcCtD
Tacrolimus—Arthralgia—Gabapentin—migraine	9.51e-05	0.000355	CcSEcCtD
Tacrolimus—Skin disorder—Timolol—migraine	9.51e-05	0.000355	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Valproic Acid—migraine	9.5e-05	0.000354	CcSEcCtD
Tacrolimus—Fatigue—Valproic Acid—migraine	9.48e-05	0.000354	CcSEcCtD
Tacrolimus—Anxiety—Gabapentin—migraine	9.48e-05	0.000354	CcSEcCtD
Tacrolimus—Hyperhidrosis—Timolol—migraine	9.47e-05	0.000353	CcSEcCtD
Tacrolimus—Mental disorder—Topiramate—migraine	9.46e-05	0.000353	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	9.45e-05	0.000352	CcSEcCtD
Tacrolimus—Pain—Valproic Acid—migraine	9.41e-05	0.000351	CcSEcCtD
Tacrolimus—Constipation—Valproic Acid—migraine	9.41e-05	0.000351	CcSEcCtD
Tacrolimus—Malnutrition—Topiramate—migraine	9.4e-05	0.000351	CcSEcCtD
Tacrolimus—Erythema—Topiramate—migraine	9.4e-05	0.000351	CcSEcCtD
Tacrolimus—Discomfort—Gabapentin—migraine	9.4e-05	0.00035	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—HTR1D—migraine	9.39e-05	0.00312	CbGpPWpGaD
Tacrolimus—Anorexia—Timolol—migraine	9.33e-05	0.000348	CcSEcCtD
Tacrolimus—Dry mouth—Gabapentin—migraine	9.3e-05	0.000347	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—HTR1A—migraine	9.27e-05	0.00308	CbGpPWpGaD
Tacrolimus—Flatulence—Topiramate—migraine	9.26e-05	0.000345	CcSEcCtD
Tacrolimus—Tension—Topiramate—migraine	9.22e-05	0.000344	CcSEcCtD
Tacrolimus—Nausea—Verapamil—migraine	9.22e-05	0.000344	CcSEcCtD
Tacrolimus—Dysgeusia—Topiramate—migraine	9.21e-05	0.000343	CcSEcCtD
Tacrolimus—Confusional state—Gabapentin—migraine	9.19e-05	0.000343	CcSEcCtD
Tacrolimus—Hypotension—Timolol—migraine	9.15e-05	0.000341	CcSEcCtD
Tacrolimus—Nervousness—Topiramate—migraine	9.13e-05	0.00034	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—TAC1—migraine	9.13e-05	0.00303	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—NPS—migraine	9.13e-05	0.00303	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—FOS—migraine	9.12e-05	0.00303	CbGpPWpGaD
Tacrolimus—Oedema—Gabapentin—migraine	9.12e-05	0.00034	CcSEcCtD
Tacrolimus—Anaphylactic shock—Gabapentin—migraine	9.12e-05	0.00034	CcSEcCtD
Tacrolimus—Back pain—Topiramate—migraine	9.09e-05	0.000339	CcSEcCtD
Tacrolimus—Feeling abnormal—Valproic Acid—migraine	9.06e-05	0.000338	CcSEcCtD
Tacrolimus—Infection—Gabapentin—migraine	9.06e-05	0.000338	CcSEcCtD
Tacrolimus—Muscle spasms—Topiramate—migraine	9.04e-05	0.000337	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Valproic Acid—migraine	9e-05	0.000335	CcSEcCtD
Tacrolimus—Shock—Gabapentin—migraine	8.97e-05	0.000335	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—HTR2C—migraine	8.95e-05	0.00297	CbGpPWpGaD
Tacrolimus—Nervous system disorder—Gabapentin—migraine	8.94e-05	0.000334	CcSEcCtD
Tacrolimus—Thrombocytopenia—Gabapentin—migraine	8.93e-05	0.000333	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Timolol—migraine	8.92e-05	0.000333	CcSEcCtD
Tacrolimus—Tachycardia—Gabapentin—migraine	8.9e-05	0.000332	CcSEcCtD
Tacrolimus—Vision blurred—Topiramate—migraine	8.86e-05	0.00033	CcSEcCtD
Tacrolimus—Skin disorder—Gabapentin—migraine	8.86e-05	0.00033	CcSEcCtD
Tacrolimus—Insomnia—Timolol—migraine	8.86e-05	0.00033	CcSEcCtD
Tacrolimus—Hyperhidrosis—Gabapentin—migraine	8.82e-05	0.000329	CcSEcCtD
Tacrolimus—Tremor—Topiramate—migraine	8.81e-05	0.000328	CcSEcCtD
Tacrolimus—Paraesthesia—Timolol—migraine	8.79e-05	0.000328	CcSEcCtD
Tacrolimus—Urticaria—Valproic Acid—migraine	8.74e-05	0.000326	CcSEcCtD
Tacrolimus—Dyspnoea—Timolol—migraine	8.73e-05	0.000326	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—HTR2B—migraine	8.73e-05	0.0029	CbGpPWpGaD
Tacrolimus—Ill-defined disorder—Topiramate—migraine	8.72e-05	0.000325	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—EDNRA—migraine	8.71e-05	0.00289	CbGpPWpGaD
Tacrolimus—Somnolence—Timolol—migraine	8.71e-05	0.000325	CcSEcCtD
Tacrolimus—Abdominal pain—Valproic Acid—migraine	8.7e-05	0.000324	CcSEcCtD
Tacrolimus—Body temperature increased—Valproic Acid—migraine	8.7e-05	0.000324	CcSEcCtD
Tacrolimus—Anorexia—Gabapentin—migraine	8.69e-05	0.000324	CcSEcCtD
Tacrolimus—Anaemia—Topiramate—migraine	8.69e-05	0.000324	CcSEcCtD
Tacrolimus—Agitation—Topiramate—migraine	8.64e-05	0.000322	CcSEcCtD
Tacrolimus—Dyspepsia—Timolol—migraine	8.62e-05	0.000321	CcSEcCtD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	8.57e-05	0.00285	CbGpPWpGaD
Tacrolimus—Hypotension—Gabapentin—migraine	8.52e-05	0.000318	CcSEcCtD
Tacrolimus—Decreased appetite—Timolol—migraine	8.51e-05	0.000317	CcSEcCtD
Tacrolimus—FKBP1A—Disease—LRP1—migraine	8.51e-05	0.00283	CbGpPWpGaD
Tacrolimus—Malaise—Topiramate—migraine	8.48e-05	0.000316	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Timolol—migraine	8.45e-05	0.000315	CcSEcCtD
Tacrolimus—Vertigo—Topiramate—migraine	8.45e-05	0.000315	CcSEcCtD
Tacrolimus—Fatigue—Timolol—migraine	8.44e-05	0.000315	CcSEcCtD
Tacrolimus—Syncope—Topiramate—migraine	8.43e-05	0.000314	CcSEcCtD
Tacrolimus—Leukopenia—Topiramate—migraine	8.41e-05	0.000314	CcSEcCtD
Tacrolimus—MTOR—Insulin Signaling—FOS—migraine	8.38e-05	0.00278	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CALCA—migraine	8.38e-05	0.00278	CbGpPWpGaD
Tacrolimus—Pain—Timolol—migraine	8.37e-05	0.000312	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Gabapentin—migraine	8.31e-05	0.00031	CcSEcCtD
Tacrolimus—Palpitations—Topiramate—migraine	8.31e-05	0.00031	CcSEcCtD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—FOS—migraine	8.3e-05	0.00276	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—MTHFR—migraine	8.3e-05	0.00276	CbGpPWpGaD
Tacrolimus—Loss of consciousness—Topiramate—migraine	8.26e-05	0.000308	CcSEcCtD
Tacrolimus—Insomnia—Gabapentin—migraine	8.25e-05	0.000308	CcSEcCtD
Tacrolimus—Cough—Topiramate—migraine	8.2e-05	0.000306	CcSEcCtD
Tacrolimus—Paraesthesia—Gabapentin—migraine	8.19e-05	0.000305	CcSEcCtD
Tacrolimus—Convulsion—Topiramate—migraine	8.14e-05	0.000304	CcSEcCtD
Tacrolimus—Dyspnoea—Gabapentin—migraine	8.13e-05	0.000303	CcSEcCtD
Tacrolimus—Hypertension—Topiramate—migraine	8.12e-05	0.000303	CcSEcCtD
Tacrolimus—Somnolence—Gabapentin—migraine	8.11e-05	0.000302	CcSEcCtD
Tacrolimus—Hypersensitivity—Valproic Acid—migraine	8.1e-05	0.000302	CcSEcCtD
Tacrolimus—Feeling abnormal—Timolol—migraine	8.07e-05	0.000301	CcSEcCtD
Tacrolimus—Dyspepsia—Gabapentin—migraine	8.03e-05	0.000299	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Timolol—migraine	8.01e-05	0.000299	CcSEcCtD
Tacrolimus—Chest pain—Topiramate—migraine	8e-05	0.000298	CcSEcCtD
Tacrolimus—Arthralgia—Topiramate—migraine	8e-05	0.000298	CcSEcCtD
Tacrolimus—Myalgia—Topiramate—migraine	8e-05	0.000298	CcSEcCtD
Tacrolimus—Anxiety—Topiramate—migraine	7.98e-05	0.000297	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	7.95e-05	0.000296	CcSEcCtD
Tacrolimus—Decreased appetite—Gabapentin—migraine	7.93e-05	0.000296	CcSEcCtD
Tacrolimus—Discomfort—Topiramate—migraine	7.91e-05	0.000295	CcSEcCtD
Tacrolimus—Asthenia—Valproic Acid—migraine	7.89e-05	0.000294	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Gabapentin—migraine	7.87e-05	0.000294	CcSEcCtD
Tacrolimus—Fatigue—Gabapentin—migraine	7.86e-05	0.000293	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—HTR7—migraine	7.84e-05	0.0026	CbGpPWpGaD
Tacrolimus—Dry mouth—Topiramate—migraine	7.83e-05	0.000292	CcSEcCtD
Tacrolimus—Constipation—Gabapentin—migraine	7.8e-05	0.000291	CcSEcCtD
Tacrolimus—Pain—Gabapentin—migraine	7.8e-05	0.000291	CcSEcCtD
Tacrolimus—Pruritus—Valproic Acid—migraine	7.78e-05	0.00029	CcSEcCtD
Tacrolimus—Urticaria—Timolol—migraine	7.78e-05	0.00029	CcSEcCtD
Tacrolimus—Abdominal pain—Timolol—migraine	7.74e-05	0.000289	CcSEcCtD
Tacrolimus—Body temperature increased—Timolol—migraine	7.74e-05	0.000289	CcSEcCtD
Tacrolimus—Confusional state—Topiramate—migraine	7.74e-05	0.000288	CcSEcCtD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FOS—migraine	7.73e-05	0.00257	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—LRP1—migraine	7.68e-05	0.00255	CbGpPWpGaD
Tacrolimus—Oedema—Topiramate—migraine	7.67e-05	0.000286	CcSEcCtD
Tacrolimus—Infection—Topiramate—migraine	7.62e-05	0.000284	CcSEcCtD
Tacrolimus—Shock—Topiramate—migraine	7.55e-05	0.000281	CcSEcCtD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	7.55e-05	0.00251	CbGpPWpGaD
Tacrolimus—Diarrhoea—Valproic Acid—migraine	7.53e-05	0.000281	CcSEcCtD
Tacrolimus—Nervous system disorder—Topiramate—migraine	7.52e-05	0.000281	CcSEcCtD
Tacrolimus—Feeling abnormal—Gabapentin—migraine	7.51e-05	0.00028	CcSEcCtD
Tacrolimus—Thrombocytopenia—Topiramate—migraine	7.51e-05	0.00028	CcSEcCtD
Tacrolimus—Tachycardia—Topiramate—migraine	7.49e-05	0.000279	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Gabapentin—migraine	7.46e-05	0.000278	CcSEcCtD
Tacrolimus—Skin disorder—Topiramate—migraine	7.45e-05	0.000278	CcSEcCtD
Tacrolimus—Hyperhidrosis—Topiramate—migraine	7.42e-05	0.000277	CcSEcCtD
Tacrolimus—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	7.41e-05	0.00246	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	7.41e-05	0.00246	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	7.33e-05	0.00243	CbGpPWpGaD
Tacrolimus—Anorexia—Topiramate—migraine	7.31e-05	0.000273	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—HTR1D—migraine	7.28e-05	0.00242	CbGpPWpGaD
Tacrolimus—Dizziness—Valproic Acid—migraine	7.27e-05	0.000271	CcSEcCtD
Tacrolimus—Urticaria—Gabapentin—migraine	7.24e-05	0.00027	CcSEcCtD
Tacrolimus—Hypersensitivity—Timolol—migraine	7.21e-05	0.000269	CcSEcCtD
Tacrolimus—Abdominal pain—Gabapentin—migraine	7.21e-05	0.000269	CcSEcCtD
Tacrolimus—Body temperature increased—Gabapentin—migraine	7.21e-05	0.000269	CcSEcCtD
Tacrolimus—Hypotension—Topiramate—migraine	7.17e-05	0.000267	CcSEcCtD
Tacrolimus—PPP3CA—Disease—CALCA—migraine	7.07e-05	0.00235	CbGpPWpGaD
Tacrolimus—Asthenia—Timolol—migraine	7.03e-05	0.000262	CcSEcCtD
Tacrolimus—Vomiting—Valproic Acid—migraine	6.99e-05	0.000261	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Topiramate—migraine	6.99e-05	0.000261	CcSEcCtD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—migraine	6.96e-05	0.00231	CbGpPWpGaD
Tacrolimus—Insomnia—Topiramate—migraine	6.94e-05	0.000259	CcSEcCtD
Tacrolimus—Rash—Valproic Acid—migraine	6.94e-05	0.000259	CcSEcCtD
Tacrolimus—Dermatitis—Valproic Acid—migraine	6.93e-05	0.000258	CcSEcCtD
Tacrolimus—Pruritus—Timolol—migraine	6.93e-05	0.000258	CcSEcCtD
Tacrolimus—Headache—Valproic Acid—migraine	6.89e-05	0.000257	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—FOS—migraine	6.89e-05	0.00229	CbGpPWpGaD
Tacrolimus—Paraesthesia—Topiramate—migraine	6.89e-05	0.000257	CcSEcCtD
Tacrolimus—Dyspnoea—Topiramate—migraine	6.84e-05	0.000255	CcSEcCtD
Tacrolimus—Somnolence—Topiramate—migraine	6.82e-05	0.000254	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—HTR2B—migraine	6.77e-05	0.00225	CbGpPWpGaD
Tacrolimus—Dyspepsia—Topiramate—migraine	6.75e-05	0.000252	CcSEcCtD
Tacrolimus—Hypersensitivity—Gabapentin—migraine	6.72e-05	0.000251	CcSEcCtD
Tacrolimus—Diarrhoea—Timolol—migraine	6.7e-05	0.00025	CcSEcCtD
Tacrolimus—Decreased appetite—Topiramate—migraine	6.67e-05	0.000249	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Topiramate—migraine	6.62e-05	0.000247	CcSEcCtD
Tacrolimus—Fatigue—Topiramate—migraine	6.61e-05	0.000247	CcSEcCtD
Tacrolimus—Constipation—Topiramate—migraine	6.56e-05	0.000245	CcSEcCtD
Tacrolimus—Pain—Topiramate—migraine	6.56e-05	0.000245	CcSEcCtD
Tacrolimus—Asthenia—Gabapentin—migraine	6.54e-05	0.000244	CcSEcCtD
Tacrolimus—Nausea—Valproic Acid—migraine	6.53e-05	0.000244	CcSEcCtD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	6.49e-05	0.00216	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	6.49e-05	0.00216	CbGpPWpGaD
Tacrolimus—Dizziness—Timolol—migraine	6.48e-05	0.000241	CcSEcCtD
Tacrolimus—Pruritus—Gabapentin—migraine	6.45e-05	0.000241	CcSEcCtD
Tacrolimus—Feeling abnormal—Topiramate—migraine	6.32e-05	0.000236	CcSEcCtD
Tacrolimus—ALB—Transmembrane transport of small molecules—HTR3A—migraine	6.3e-05	0.00209	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Topiramate—migraine	6.27e-05	0.000234	CcSEcCtD
Tacrolimus—Diarrhoea—Gabapentin—migraine	6.24e-05	0.000233	CcSEcCtD
Tacrolimus—Vomiting—Timolol—migraine	6.23e-05	0.000232	CcSEcCtD
Tacrolimus—Rash—Timolol—migraine	6.17e-05	0.00023	CcSEcCtD
Tacrolimus—Dermatitis—Timolol—migraine	6.17e-05	0.00023	CcSEcCtD
Tacrolimus—Headache—Timolol—migraine	6.13e-05	0.000229	CcSEcCtD
Tacrolimus—Urticaria—Topiramate—migraine	6.09e-05	0.000227	CcSEcCtD
Tacrolimus—Body temperature increased—Topiramate—migraine	6.06e-05	0.000226	CcSEcCtD
Tacrolimus—Abdominal pain—Topiramate—migraine	6.06e-05	0.000226	CcSEcCtD
Tacrolimus—Dizziness—Gabapentin—migraine	6.03e-05	0.000225	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—LRP1—migraine	5.96e-05	0.00198	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NOTCH4—migraine	5.9e-05	0.00196	CbGpPWpGaD
Tacrolimus—Nausea—Timolol—migraine	5.82e-05	0.000217	CcSEcCtD
Tacrolimus—Vomiting—Gabapentin—migraine	5.8e-05	0.000216	CcSEcCtD
Tacrolimus—Rash—Gabapentin—migraine	5.75e-05	0.000214	CcSEcCtD
Tacrolimus—Dermatitis—Gabapentin—migraine	5.74e-05	0.000214	CcSEcCtD
Tacrolimus—Headache—Gabapentin—migraine	5.71e-05	0.000213	CcSEcCtD
Tacrolimus—PPP3CA—Disease—TGFBR2—migraine	5.7e-05	0.00189	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HTR1B—migraine	5.69e-05	0.00189	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Topiramate—migraine	5.65e-05	0.000211	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—CALCRL—migraine	5.63e-05	0.00187	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RAMP1—migraine	5.63e-05	0.00187	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—FOS—migraine	5.62e-05	0.00187	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—TNF—migraine	5.53e-05	0.00184	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	5.52e-05	0.00183	CbGpPWpGaD
Tacrolimus—Asthenia—Topiramate—migraine	5.5e-05	0.000205	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—HTR2A—migraine	5.49e-05	0.00182	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CALCA—migraine	5.48e-05	0.00182	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HTR1A—migraine	5.48e-05	0.00182	CbGpPWpGaD
Tacrolimus—Pruritus—Topiramate—migraine	5.43e-05	0.000202	CcSEcCtD
Tacrolimus—Nausea—Gabapentin—migraine	5.42e-05	0.000202	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—NPS—migraine	5.39e-05	0.00179	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TAC1—migraine	5.39e-05	0.00179	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PGR—migraine	5.39e-05	0.00179	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HTR2C—migraine	5.29e-05	0.00176	CbGpPWpGaD
Tacrolimus—Diarrhoea—Topiramate—migraine	5.25e-05	0.000196	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—EDNRA—migraine	5.14e-05	0.00171	CbGpPWpGaD
Tacrolimus—Dizziness—Topiramate—migraine	5.07e-05	0.000189	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—NOTCH3—migraine	5.01e-05	0.00167	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CALCA—migraine	4.95e-05	0.00164	CbGpPWpGaD
Tacrolimus—Vomiting—Topiramate—migraine	4.88e-05	0.000182	CcSEcCtD
Tacrolimus—Rash—Topiramate—migraine	4.84e-05	0.00018	CcSEcCtD
Tacrolimus—Dermatitis—Topiramate—migraine	4.83e-05	0.00018	CcSEcCtD
Tacrolimus—Headache—Topiramate—migraine	4.81e-05	0.000179	CcSEcCtD
Tacrolimus—MTOR—Disease—LRP1—migraine	4.79e-05	0.00159	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.64e-05	0.00154	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HTR7—migraine	4.63e-05	0.00154	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—MTHFR—migraine	4.63e-05	0.00154	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOTCH4—migraine	4.57e-05	0.00152	CbGpPWpGaD
Tacrolimus—Nausea—Topiramate—migraine	4.56e-05	0.00017	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—TNF—migraine	4.5e-05	0.00149	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFBR2—migraine	4.42e-05	0.00147	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR1B—migraine	4.41e-05	0.00146	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR1A—migraine	4.25e-05	0.00141	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TAC1—migraine	4.18e-05	0.00139	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PGR—migraine	4.18e-05	0.00139	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NPS—migraine	4.18e-05	0.00139	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR2C—migraine	4.1e-05	0.00136	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR1D—migraine	4.09e-05	0.00136	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CACNA1A—migraine	4.03e-05	0.00134	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—FOS—migraine	4.01e-05	0.00133	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EDNRA—migraine	3.99e-05	0.00132	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFBR2—migraine	3.99e-05	0.00132	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOTCH3—migraine	3.89e-05	0.00129	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CALCA—migraine	3.84e-05	0.00128	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2B—migraine	3.81e-05	0.00126	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR7—migraine	3.59e-05	0.00119	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MTHFR—migraine	3.59e-05	0.00119	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—migraine	3.57e-05	0.00119	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.48e-05	0.00115	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—migraine	3.41e-05	0.00113	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LRP1—migraine	3.35e-05	0.00111	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HTR2A—migraine	3.24e-05	0.00108	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFBR2—migraine	3.09e-05	0.00103	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CALCA—migraine	3.08e-05	0.00102	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—FOS—migraine	3e-05	0.000998	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CACNA1A—migraine	2.91e-05	0.000968	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ESR1—migraine	2.88e-05	0.000956	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOTCH4—migraine	2.57e-05	0.000854	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR2A—migraine	2.52e-05	0.000835	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CACNA1A—migraine	2.51e-05	0.000833	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFBR2—migraine	2.48e-05	0.000825	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR1B—migraine	2.48e-05	0.000824	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR1A—migraine	2.39e-05	0.000793	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PGR—migraine	2.35e-05	0.000781	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NPS—migraine	2.35e-05	0.000781	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TAC1—migraine	2.35e-05	0.000781	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2C—migraine	2.31e-05	0.000766	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EDNRA—migraine	2.24e-05	0.000745	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ESR1—migraine	2.23e-05	0.000742	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CACNA1A—migraine	2.2e-05	0.00073	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOTCH3—migraine	2.19e-05	0.000726	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CALCA—migraine	2.16e-05	0.000717	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR7—migraine	2.02e-05	0.000671	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MTHFR—migraine	2.02e-05	0.00067	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FOS—migraine	1.75e-05	0.000581	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFBR2—migraine	1.74e-05	0.000578	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.68e-05	0.000559	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2A—migraine	1.41e-05	0.00047	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CACNA1A—migraine	1.35e-05	0.00045	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—migraine	1.33e-05	0.000443	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ESR1—migraine	1.26e-05	0.000417	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—migraine	9.64e-06	0.00032	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—migraine	8.3e-06	0.000276	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—migraine	7.27e-06	0.000242	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—migraine	4.48e-06	0.000149	CbGpPWpGaD
